Detalhe da pesquisa
1.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30299429
2.
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.
J Immunother Cancer
; 12(5)2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38702147
3.
Management of Pain Medication in Patients With a History of Bariatric Surgery: A Systematic Review.
J Pain Symptom Manage
; 67(6): e859-e868, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309443
4.
Individualizing busulfan dose in specific populations and evaluating the risk of pharmacokinetic drug-drug interactions.
Expert Opin Drug Metab Toxicol
; 19(2): 75-90, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939456
5.
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Front Immunol
; 14: 1270081, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920468
6.
Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.
J Immunother Cancer
; 8(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32784216
7.
Pharmacokinetics/Pharmacodynamic (PK/PD) relationship of therapeutic monoclonal antibodies used in oncology: what's new?
Eur J Cancer
; 128: 103-106, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32089494
8.
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers.
Eur J Cancer
; 128: 107-118, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037061
9.
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies.
Eur J Cancer
; 128: 119-128, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037060
10.
Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer.
Cancers (Basel)
; 12(12)2020 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33327482
11.
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas.
Eur J Cancer
; 90: 83-91, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29274619
12.
Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies.
Int J Pharm
; 532(2): 748-756, 2017 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28546071
13.
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations.
Leukemia
; 32(9): 2008-2081, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29479068